1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Spyroulias, G.A.
Papazacharias, S.
Pairas, G.
Cordopatis, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C4 H9 N O2
103.120
n
ALPHA-AMINOISOBUTYRIC ACID
L-peptide linking
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C9 H11 N O2
165.189
D-PHENYLALANINE
D-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
269
6009
10.1046/J.1432-1033.2002.03278.X
12473096
Monitoring the Structural Consequences of Phe12-->D-Phe and Leu15-->Aib Substitution in Human/Rat Corticotropin Releasing Hormone. Implications for Design of Crh Antagonists.
2002
UK
Protein Eng.
PRENE9
0859
0269-2139
6
149
10.1093/PROTEIN/6.2.149
8386360
Solution Structure of Human Corticotropin Releasing Factor by 1H NMR and Distance Geometry with Restrained Molecular Dynamics.
1993
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
SYNTHETIC ANALOGUE WITH ISOLEUCINE-AMIDE C-TERMINUS
4734.436
CORTICOTROPIN RELEASING HORMONE
YES
1
syn
polymer
CORTICOLIBERIN
no
yes
SEEPPISLDLT(DPN)HL(AIB)REVLEMARAEQLAQQAHSNRKLMEII(NH2)
SEEPPISLDLTFHLAREVLEMARAEQLAQQAHSNRKLMEIIX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Database references
Derived calculations
Other
Source and taxonomy
Structure summary
Version format compliance
1
0
2001-10-31
1
1
2016-12-21
PDBE
Y
PDBE
2001-10-20
REL
SYNTHETIC ANALOGUE SYNTHESIZED THROUGH SOLID PHASE SYNTHESIS USING FMOC/TBU SYNTHETIC PROTOCOLS. NATIVE PHE12 AND LEU15 HAS BEEN SUBSTITUTED BY D-PHE AND ALPHA-AMINOISOBUTYRIC ACID
9606
HUMAN
HOMO SAPIENS
sample
MEAN STRUCTURE. THE STRUCTURE WAS DETERMINED USING 1H-1H DOUBLE-RESONANCE NMR SPECTROSCOPY. NMR-DERRIVED DISTANCE RESTRAINTS AND 3JHAHN COUPLING CONSTANTS AS WELL AS H-BOND CONSTRAINTS USED IN STRUCTURAL CALCULATION AND REFIMENT PROCEEDURE.
LEAST RESTRAINT VIOLATION
40
1
COSY
TOCSY
NOESY
3.8
pH
1
atm
310
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
HYBRID DISTANCE GEOMETRY SIMULATED ANNEALING IN TORSION ANGLE SPACE
34% H2O / 66% TFE
PETER KOLLMAN, DAVE CASE, KEN MERZ, THOMAS CHEATHAM, CARLOS SIMMERLING, TOM DARDEN
refinement
AMBER
5.0
structure solution
DYANA
structure solution
AMBER
600
Bruker
AMX
SER
1
n
1
SER
1
A
GLU
2
n
2
GLU
2
A
GLU
3
n
3
GLU
3
A
PRO
4
n
4
PRO
4
A
PRO
5
n
5
PRO
5
A
ILE
6
n
6
ILE
6
A
SER
7
n
7
SER
7
A
LEU
8
n
8
LEU
8
A
ASP
9
n
9
ASP
9
A
LEU
10
n
10
LEU
10
A
THR
11
n
11
THR
11
A
DPN
12
n
12
DPN
12
A
HIS
13
n
13
HIS
13
A
LEU
14
n
14
LEU
14
A
AIB
15
n
15
AIB
15
A
ARG
16
n
16
ARG
16
A
GLU
17
n
17
GLU
17
A
VAL
18
n
18
VAL
18
A
LEU
19
n
19
LEU
19
A
GLU
20
n
20
GLU
20
A
MET
21
n
21
MET
21
A
ALA
22
n
22
ALA
22
A
ARG
23
n
23
ARG
23
A
ALA
24
n
24
ALA
24
A
GLU
25
n
25
GLU
25
A
GLN
26
n
26
GLN
26
A
LEU
27
n
27
LEU
27
A
ALA
28
n
28
ALA
28
A
GLN
29
n
29
GLN
29
A
GLN
30
n
30
GLN
30
A
ALA
31
n
31
ALA
31
A
HIS
32
n
32
HIS
32
A
SER
33
n
33
SER
33
A
ASN
34
n
34
ASN
34
A
ARG
35
n
35
ARG
35
A
LYS
36
n
36
LYS
36
A
LEU
37
n
37
LEU
37
A
MET
38
n
38
MET
38
A
GLU
39
n
39
GLU
39
A
ILE
40
n
40
ILE
40
A
ILE
41
n
41
ILE
41
A
NH2
42
n
42
NH2
42
A
author_defined_assembly
1
monomeric
A
AIB
15
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
15
ALA
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
GLU
17
-96.34
-67.34
CORTICOTROPIN RELEASING HORMONE
MINIMIZED AVERAGE
Monitoring the structural Consequences of Phe12-->D-Phe12 and Leu15-->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for Design of CRH antagonists.
1
N
N
A
ILE
6
A
ILE
6
HELX_P
A
VAL
18
A
VAL
18
1
1
13
A
GLU
20
A
GLU
20
HELX_P
A
ILE
40
A
ILE
40
1
2
21
covale
1.333
A
THR
11
A
C
THR
11
1_555
A
DPN
12
A
N
DPN
12
1_555
covale
1.333
A
DPN
12
A
C
DPN
12
1_555
A
HIS
13
A
N
HIS
13
1_555
covale
1.334
A
LEU
14
A
C
LEU
14
1_555
A
AIB
15
A
N
AIB
15
1_555
covale
1.338
A
AIB
15
A
C
AIB
15
1_555
A
ARG
16
A
N
ARG
16
1_555
covale
1.333
A
ILE
41
A
C
ILE
41
1_555
A
NH2
42
A
N
NH2
42
1_555
HORMONE
HORMONE, CORTICOTROPIN RELEASING HORMONE, SYNTHETIC ANALOGUES, SOLID PHASE SYNTHESIS, SOLUTIONS STRUCTURE
CRF_HUMAN
UNP
1
P06850
154
194
1GO9
1
41
P06850
A
1
1
41
1
PHE
engineered mutation
DPN
12
1GO9
A
P06850
UNP
165
12
1
LEU
engineered mutation
AIB
15
1GO9
A
P06850
UNP
168
15
1
amidation
NH2
42
1GO9
A
P06850
UNP
42
1
P 1